Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group
View ORCID ProfileAna Beatriz C Cazé, View ORCID ProfileThiago Cerqueira-Silva, Adriele Pinheiro Bomfim, Gisley Lima de Souza, Amanda Canário Andrade Azevedo, Michelle Queiroz Aguiar Brasil, Nara Rúbia Santos, Ricardo Khouri, Jennifer Dan, Antonio Carlos Bandeira, Luciano Pamplona de Goes Cavalcanti, View ORCID ProfileManoel Barral-Netto, Aldina Maria Prado Barral, Cynara Gomes Barbosa, View ORCID ProfileViviane Sampaio Boaventura
doi: https://doi.org/10.1101/2022.09.15.22279958
Ana Beatriz C Cazé
1Universidade Federal da Bahia, Salvador, Bahia, Brazil
Thiago Cerqueira-Silva
2LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
1Universidade Federal da Bahia, Salvador, Bahia, Brazil
MDAdriele Pinheiro Bomfim
4Instituto Gonçalo Muniz, Fiocruz, Salvador, Brazil
1Universidade Federal da Bahia, Salvador, Bahia, Brazil
M. Sc.Gisley Lima de Souza
6Escola de Medicina e Saúde Pública da Bahia
7Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
Amanda Canário Andrade Azevedo
8Hospital Santa Izabel, Santa Casa da Bahia, Salvador, Bahia, Brazil
MD, M.Sc.Michelle Queiroz Aguiar Brasil
7Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
10Federal University of Bahia, Salvador, Bahia, Brazil
MD, M. Sc.Nara Rúbia Santos
11Departamento de Vigilância em Saúde/Vigilância Epidemiológica, Campo Formoso, Bahia Brazil
Ricardo Khouri
12Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Clinical and Epidemiological Virology, Belgium
7Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
PhDJennifer Dan
14Center for Infectious Disease and Vaccine Research, la Jolla Institute for Immunology (LJI)
15Department of Medicine, Division of Infectious Disease and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA
MD, PhDAntonio Carlos Bandeira
16UNI-FTC-Faculdade Tecnologia Ciências Medical School, Bahia
17Central State Laboratory LACEN-Bahia
MD, PhDRoles: Infectious Diseases Advisor
Luciano Pamplona de Goes Cavalcanti
18Universidade Federal do Ceará, Fortaleza, Ceará, Brazil
19Centro Universitario Christus, Fortaleza, Ceará, Brazil
MD, PhDManoel Barral-Netto
2LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
1Universidade Federal da Bahia, Salvador, Bahia, Brazil
MD, PhDAldina Maria Prado Barral
22Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil
23Instituto de Investigação em Imunologia, São Paulo, São Paulo, Brazil
Cynara Gomes Barbosa
24Universidade Federal da Bahia, Salvador, Brazil
PhDViviane Sampaio Boaventura
2LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
1Universidade Federal da Bahia, Salvador, Bahia, Brazil
MD, PhDData Availability
Availability of data and materials: The dataset generated and/or analyzed during the current study are not publicly available due to legal and ethical restrictions. Dataset are available upon request.
Posted September 22, 2022.
Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group
Ana Beatriz C Cazé, Thiago Cerqueira-Silva, Adriele Pinheiro Bomfim, Gisley Lima de Souza, Amanda Canário Andrade Azevedo, Michelle Queiroz Aguiar Brasil, Nara Rúbia Santos, Ricardo Khouri, Jennifer Dan, Antonio Carlos Bandeira, Luciano Pamplona de Goes Cavalcanti, Manoel Barral-Netto, Aldina Maria Prado Barral, Cynara Gomes Barbosa, Viviane Sampaio Boaventura
medRxiv 2022.09.15.22279958; doi: https://doi.org/10.1101/2022.09.15.22279958
Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group
Ana Beatriz C Cazé, Thiago Cerqueira-Silva, Adriele Pinheiro Bomfim, Gisley Lima de Souza, Amanda Canário Andrade Azevedo, Michelle Queiroz Aguiar Brasil, Nara Rúbia Santos, Ricardo Khouri, Jennifer Dan, Antonio Carlos Bandeira, Luciano Pamplona de Goes Cavalcanti, Manoel Barral-Netto, Aldina Maria Prado Barral, Cynara Gomes Barbosa, Viviane Sampaio Boaventura
medRxiv 2022.09.15.22279958; doi: https://doi.org/10.1101/2022.09.15.22279958
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12891)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4684)
- Geriatric Medicine (431)
- Health Economics (738)
- Health Informatics (2981)
- Health Policy (1081)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (437)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4474)
- Nursing (239)
- Nutrition (656)
- Oncology (2322)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1212)
- Primary Care Research (509)
- Public and Global Health (7060)
- Radiology and Imaging (1570)
- Respiratory Medicine (930)
- Rheumatology (449)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)